MedPath

Serum interleukin changes in gastric bypass surgery, before and after general anesthesia with isoflurane and propofol .

Phase 1
Conditions
aparoscopic Gastric Bypass.
Morbid obesity
Registration Number
IRCT2015111812642N22
Lead Sponsor
Vice chancellor for research, Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
64
Inclusion Criteria

Patients undergoing laparoscopic gastric bypass; ASA Class II -III; morbid obesity (BMI> = 35 kg / m2); Exclusion criteria: With cardiovascular and respiratory diseases, drug and alcohol abuse, renal failure, liver dysfunction and autoimmune disease, diabetes or asthma disease, regular use of steroids and NSAID; core temperature greater than 37 ° C, the number of cells white More than 10 thousand

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath